Journal of Skin and Stem Cell

Published by: Kowsar

Comparison of Therapeutic Response of Keloids to Cryotherapy Plus Intralesional Triamcinolone Acetonide or Verapamil Hydrochloride

Parvin Jannati 1 , Saeed Aref 1 , * , Ahmad Amin Jannati 1 , Faezeh Jannati 2 and Hamideh Moravvej 1
Authors Information
1 Department of Dermatology, Skin Research Center, Shohada-e- Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Dermatology, Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: March 31, 2015, 2 (1); e29284
  • Published Online: March 21, 2015
  • Article Type: Research Article
  • Received: January 15, 2015
  • Accepted: February 10, 2015
  • DOI: 10.17795/jssc2928

To Cite: Jannati P, Aref S, Jannati A A, Jannati F, Moravvej H. Comparison of Therapeutic Response of Keloids to Cryotherapy Plus Intralesional Triamcinolone Acetonide or Verapamil Hydrochloride, J Skin Stem Cell. 2015 ; 2(1):e29284. doi: 10.17795/jssc2928.

Abstract
Copyright © 2015, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Song N, Wu X, Gao Z, Zhou G, Zhang WJ, Liu W. Enhanced expression of membrane transporter and drug resistance in keloid fibroblasts. Hum Pathol. 2012; 43(11): 2024-32[DOI][PubMed]
  • 2. Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014; 32(2): 193-209[DOI][PubMed]
  • 3. Unahabhokha T, Sucontphunt A, Nimmannit U, Chanvorachote P, Yongsanguanchai N, Pongrakhananon V. Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds. Pharmace biol. 2014; : 1-7
  • 4. Cavalie M, Sillard L, Montaudie H, Bahadoran P, Lacour JP, Passeron T. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther. 2015; 28(2): 74-8[DOI][PubMed]
  • 5. Goyal NN, Gold MH. A novel triple medicine combination injection for the resolution of keloids and hypertrophic scars. J Clin Aesthet Dermatol. 2014; 7(11): 31-4[PubMed]
  • 6. Lee SY, Park J. Postoperative electron beam radiotherapy for keloids: treatment outcome and factors associated with occurrence and recurrence. Ann Dermatol. 2015; 27(1): 53-8[DOI][PubMed]
  • 7. Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burns. 2014; 40(4): 583-8[DOI][PubMed]
  • 8. Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol. 2008; 74(4): 343-8[PubMed]
  • 9. Ghazizadeh M. Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nippon Med Sch. 2007; 74(1): 11-22[PubMed]
  • 10. Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res. 2000; 89(1): 74-7[DOI][PubMed]
  • 11. Giugliano G, Pasquali D, Notaro A, Brongo S, Nicoletti G, D'Andrea F, et al. Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts. British Journal of Plastic Surgery. 2003; 56(8): 804-9[DOI]
  • 12. Xu SJ, Teng JY, Xie J, Shen MQ, Chen DM. [Comparison of the mechanisms of intralesional steroid, interferon or verapamil injection in the treatment of proliferative scars]. Chinese J Plastic Surg. 2009; 25(1): 37-40
  • 13. Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil. 2004; 25(1): 1-7[DOI][PubMed]
  • 14. Lee RC, Ping JA. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res. 1990; 49(5): 463-6[PubMed]
  • 15. Song C. Hypertrophic scars and keloids in surgery: current concepts. Ann Plast Surg. 2014; 73 Suppl 1-18[DOI][PubMed]
  • 16. Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009; 80(3): 253-60[PubMed]
  • 17. D'Andrea F, Brongo S, Ferraro G, Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2002; 204(1): 60-2[PubMed]
  • 18. Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg. 1996; 37(2): 167-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments